{"id":"https://openalex.org/W7225634385","doi":"https://doi.org/10.1080/17576180.2026.2758032","title":"Bioanalysis of antibody\u2013drug conjugates: current practices and future directions\u2014a workshop report","display_name":"Bioanalysis of antibody\u2013drug conjugates: current practices and future directions\u2014a workshop report","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225634385","doi":"https://doi.org/10.1080/17576180.2026.2758032","pmid":"https://pubmed.ncbi.nlm.nih.gov/43001791"},"language":"en","primary_location":{"id":"doi:10.1080/17576180.2026.2758032","doi":"https://doi.org/10.1080/17576180.2026.2758032","is_oa":true,"landing_page_url":"https://doi.org/10.1080/17576180.2026.2758032","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/17576180.2026.2758032?needAccess=true","source":{"id":"https://openalex.org/S159955403","display_name":"Bioanalysis","issn_l":"1757-6180","issn":["1757-6180","1757-6199"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/17576180.2026.2758032?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5122023331","display_name":"Weifeng Xu","orcid":"https://orcid.org/0000-0001-7598-1489","observed_orcids":["https://orcid.org/0000-0001-7598-1489"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weifeng Xu","raw_affiliation_strings":["Merck & Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007169910","display_name":"Tushar S. Garimella","orcid":"https://orcid.org/0000-0001-8792-5513","observed_orcids":["https://orcid.org/0000-0001-8792-5513"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tushar Garimella","raw_affiliation_strings":["Daiichi Sankyo Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Sankyo Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112102258","display_name":"Brian P. Booth","orcid":"https://orcid.org/0009-0002-3812-4060","observed_orcids":["https://orcid.org/0009-0002-3812-4060"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Booth","raw_affiliation_strings":["Office of Clinical Pharmacology (OCP), US FDA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Clinical Pharmacology (OCP), US FDA","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050449302","display_name":"N. Ezgi Wood","orcid":"https://orcid.org/0000-0002-1874-9226","observed_orcids":["https://orcid.org/0000-0002-1874-9226"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Ezgi Wood","raw_affiliation_strings":["Bristol Myers Squibb"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005988952","display_name":"Ola M. Saad","orcid":"https://orcid.org/0000-0002-2607-8901","observed_orcids":["https://orcid.org/0000-0002-2607-8901"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ola M. Saad","raw_affiliation_strings":["Genentech"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100690922","display_name":"Ang Liu","orcid":"https://orcid.org/0000-0001-9353-0948","observed_orcids":["https://orcid.org/0000-0001-9353-0948","https://orcid.org/0009-0003-3518-9050"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ang Liu","raw_affiliation_strings":["J&J Innovative Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"J&J Innovative Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112699601","display_name":"Li Wenkui","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Wenkui Li","raw_affiliation_strings":["Novartis Biomedical Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Biomedical Research","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005799156","display_name":"Faye Vazvaei-Smith","orcid":"https://orcid.org/0000-0002-8181-8335","observed_orcids":["https://orcid.org/0000-0002-8181-8335"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Faye Vazvaei-Smith","raw_affiliation_strings":["Merck & Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5005799156","https://openalex.org/A5112699601"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":1.0},{"id":"https://openalex.org/keywords/risk-based-approach","display_name":"risk-based approach","score":0.6769999861717224},{"id":"https://openalex.org/keywords/clinical-pharmacology","display_name":"clinical pharmacology","score":0.8019999861717224},{"id":"https://openalex.org/keywords/pharmacokinetic-modeling","display_name":"pharmacokinetic modeling","score":0.9190000295639038},{"id":"https://openalex.org/keywords/exposure-response-model","display_name":"exposure-response modeling","score":0.953000009059906},{"id":"https://openalex.org/keywords/immunogenicity-assessment","display_name":"immunogenicity assessment","score":0.9300000071525574},{"id":"https://openalex.org/keywords/lc-ms-ms","display_name":"LC-MS/MS","score":0.8949999809265137},{"id":"https://openalex.org/keywords/regulatory-aspects","display_name":"regulatory considerations","score":0.7699999809265137},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.6340000033378601},{"id":"https://openalex.org/keywords/regulatory-alignment","display_name":"regulatory alignment","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.6717000007629395},{"id":"https://openalex.org/C137535248","wikidata":"https://www.wikidata.org/wiki/Q4914691","display_name":"Bioanalysis","level":2,"score":0.6629999876022339},{"id":"https://openalex.org/C55587333","wikidata":"https://www.wikidata.org/wiki/Q1133029","display_name":"Engineering ethics","level":1,"score":0.4945000112056732},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.4765999913215637},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4433000087738037},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.4115999937057495},{"id":"https://openalex.org/C3019398576","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory agency","level":2,"score":0.4043000042438507},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.382099986076355},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.35109999775886536},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33480000495910645},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.32760000228881836},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.32339999079704285},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.3230000138282776},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.32260000705718994},{"id":"https://openalex.org/C2909155969","wikidata":"https://www.wikidata.org/wiki/Q6055890","display_name":"Funding Agency","level":2,"score":0.31779998540878296},{"id":"https://openalex.org/C184356942","wikidata":"https://www.wikidata.org/wiki/Q830382","display_name":"Best practice","level":2,"score":0.30970001220703125},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.3091999888420105},{"id":"https://openalex.org/C110354214","wikidata":"https://www.wikidata.org/wiki/Q6314146","display_name":"Engineering management","level":1,"score":0.304500013589859},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.29679998755455017},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.2944999933242798},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.2930999994277954},{"id":"https://openalex.org/C3020792226","wikidata":"https://www.wikidata.org/wiki/Q1331083","display_name":"Human use","level":2,"score":0.2815999984741211},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.2759000062942505},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.27459999918937683},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2712000012397766},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.26899999380111694},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.2667999863624573},{"id":"https://openalex.org/C2779965156","wikidata":"https://www.wikidata.org/wiki/Q5227350","display_name":"Data sharing","level":3,"score":0.2565000057220459},{"id":"https://openalex.org/C2777720028","wikidata":"https://www.wikidata.org/wiki/Q18394118","display_name":"Responsible Research and Innovation","level":2,"score":0.25290000438690186},{"id":"https://openalex.org/C118530786","wikidata":"https://www.wikidata.org/wiki/Q1134732","display_name":"Instrumentation (computer programming)","level":2,"score":0.2513999938964844},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.2502000033855438}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/17576180.2026.2758032","doi":"https://doi.org/10.1080/17576180.2026.2758032","is_oa":true,"landing_page_url":"https://doi.org/10.1080/17576180.2026.2758032","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/17576180.2026.2758032?needAccess=true","source":{"id":"https://openalex.org/S159955403","display_name":"Bioanalysis","issn_l":"1757-6180","issn":["1757-6180","1757-6199"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"journal-article"},{"id":"pmid:43001791","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43001791","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/17576180.2026.2758032","doi":"https://doi.org/10.1080/17576180.2026.2758032","is_oa":true,"landing_page_url":"https://doi.org/10.1080/17576180.2026.2758032","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/17576180.2026.2758032?needAccess=true","source":{"id":"https://openalex.org/S159955403","display_name":"Bioanalysis","issn_l":"1757-6180","issn":["1757-6180","1757-6199"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225634385.pdf","grobid_xml":"https://content.openalex.org/works/W7225634385.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W2018478612","https://openalex.org/W2123635951","https://openalex.org/W2782267088","https://openalex.org/W2950827632","https://openalex.org/W3163659354","https://openalex.org/W3195991203","https://openalex.org/W4220847494","https://openalex.org/W4297210376","https://openalex.org/W4297236733","https://openalex.org/W4297262422","https://openalex.org/W4391785893","https://openalex.org/W4393251493","https://openalex.org/W4393993157","https://openalex.org/W4409314540","https://openalex.org/W4409441875","https://openalex.org/W4410007645","https://openalex.org/W4410571410","https://openalex.org/W4411939223","https://openalex.org/W4413116692","https://openalex.org/W4413980811","https://openalex.org/W4414757289","https://openalex.org/W7117785873","https://openalex.org/W7118493634","https://openalex.org/W7130306011"],"related_works":["https://openalex.org/W1981480968","https://openalex.org/W7166837932","https://openalex.org/W4297236733","https://openalex.org/W2604840086","https://openalex.org/W1998924448","https://openalex.org/W7117977938","https://openalex.org/W2417088662","https://openalex.org/W4292736875","https://openalex.org/W4409314540","https://openalex.org/W2989087245"],"abstract_inverted_index":{"The":[0,27],"International":[1],"Consortium":[2],"for":[3,43,154],"Innovation":[4],"and":[5,35,63,77,79,99,101,140,143,160],"Quality":[6],"in":[7,20,23,137,163],"Pharmaceutical":[8],"Development":[9],"(IQ)":[10],"convened":[11],"a":[12,152],"workshop":[13],"on":[14,54,59,72],"bioanalysis":[15],"of":[16,88,123,134],"antibody-drug":[17],"conjugates":[18],"(ADCs)":[19],"March":[21],"2026,":[22],"Spring":[24],"House,":[25],"Pennsylvania.":[26],"one-day":[28],"event":[29],"brought":[30],"together":[31],"pharmaceutical":[32],"industry":[33,52],"scientists":[34],"regulatory":[36,64,115,161],"agency":[37],"representatives":[38],"to":[39,146],"discuss":[40],"bioanalytical":[41,157],"strategies":[42,104],"ADC":[44,60,156],"development.":[45],"This":[46],"report":[47],"summarizes":[48],"key":[49],"presentations-including":[50],"an":[51],"survey":[53],"the":[55,120,131],"current":[56],"practices,":[57],"perspectives":[58],"clinical":[61],"pharmacology,":[62],"considerations-along":[65],"with":[66],"findings":[67],"from":[68],"breakout":[69],"sessions":[70],"focused":[71],"preclinical":[73],"bioanalysis,":[74],"pharmacokinetic":[75],"assays":[76],"modeling,":[78],"immunogenicity":[80,147],"assessments.":[81],"Workshop":[82],"participants":[83],"generally":[84],"supported":[85,109],"early":[86],"characterization":[87],"relevant":[89],"ADC-related":[90],"analytes,":[91],"emphasizing":[92],"that":[93,102],"analyte":[94],"selection":[95],"should":[96],"remain":[97],"risk-based":[98,144],"molecule-specific":[100],"measurement":[103],"may":[105],"be":[106],"streamlined":[107],"when":[108,113],"by":[110],"data":[111],"and,":[112],"appropriate,":[114],"consultation.":[116],"Emerging":[117],"themes":[118],"included":[119],"growing":[121],"use":[122],"hybrid":[124],"liquid":[125],"chromatography-tandem":[126],"mass":[127],"spectrometry":[128],"(LC-MS/MS)":[129],"platforms,":[130],"central":[132],"role":[133],"exposure-response":[135],"modeling":[136],"dose":[138],"optimization":[139],"assay":[141],"strategy,":[142],"approaches":[145],"assessment.":[148],"These":[149],"discussions":[150],"provide":[151],"foundation":[153],"advancing":[155],"best":[158],"practices":[159],"alignment":[162],"this":[164],"rapidly":[165],"evolving":[166],"therapeutic":[167],"area.":[168]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}